Livdelzi savings card: as little as $0 a fill with commercial insurance

How to pay the least

Ask for the cash price

Livdelzi

We didn’t find one.

Ask your pharmacy for Livdelzi’s cash price, and one or two other pharmacies too.
Livdelzi’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Support Path Patient Assistance Program. Or call 1-855-769-7284.

See if you qualify

Compare every option

Brand nameLivdelzi

Authorized genericseladelpar lysine

Regular genericseladelpar lysine

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Livdelzi?

The original

–

Brand nameThe maker’s card

Livdelzi Co-pay Savings Program (Gilead Support Path)

Savings card from Gilead Sciences

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a fill

In the maker’s words

“You may pay as low as a $0 co-pay with the LIVDELZI Co-pay Savings Program…”

From the maker’s offer on livdelzi.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Livdelzi itself, from the same company, sold without the brand name, and usually for less. For now Livdelzi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Primary biliary cholangitis (PBC, a liver disease)

What the FDA label says

LIVDELZI is a peroxisome proliferator-activated receptor (PPAR)-delta agonist indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.

This indication is approved under accelerated approval based on a reduction of alkaline phosphatase (ALP). Improvement in survival or prevention of liver decompensation events have not been demonstrated. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).

Limitations of Use

Use of LIVDELZI is not recommended in patients who have or develop decompensated cirrhosis (e.g., ascites, variceal bleeding, hepatic encephalopathy).

Source: the FDA label for Livdelzi (Gilead Sciences, Inc), February 3, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/livdelzi/